Share Email Print
cover

Proceedings Paper

Transport, localization, and phototoxicity of m-THPC
Author(s): David Kessel; Elizabeth Sykes
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Since the photosensitizing agent mTHPC is insoluble in water, a formulation procedure, usually involving poly(ethylene glycol) and ethanol, is required for clinical and pre-clinical studies. Using this vehicle, we found that drug accumulation by murine leukemia L1210 cells in vitro was slow; only non-viable cells with damaged membranes showed rapid uptake of mTHPC. The drug ultimately localized in the cytosol, and subsequent irradiation led to mitochondrial > lysosomal >> membrane photodamage, and a rapid apoptotic response. The rate-limiting step in drug accumulation appears to involve dissociation of a transient albumin-bound aggregated species which exhibited a low fluorescence yield. Initial formation of this product may explain the unusual mTHPC pharmacokinetics in man recently reported. Dilution of mTHPC with human plasma led to a gradual increase in fluorescence yield as the drug became associated with lipoproteins and proteins. When a steady-state was reached, density-gradient ultracentrifugation indicated distribution of mTHPC to HDL > LDL >> albumin.

Paper Details

Date Published: 6 July 1999
PDF: 6 pages
Proc. SPIE 3592, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy VIII, (6 July 1999); doi: 10.1117/12.351504
Show Author Affiliations
David Kessel, Wayne State Univ. School of Medicine (United States)
Elizabeth Sykes, William Beaumont Hospital (United States)


Published in SPIE Proceedings Vol. 3592:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy VIII
Thomas J. Dougherty, Editor(s)

© SPIE. Terms of Use
Back to Top